Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
preterm birth
MedTech
Mirvie mRNA study predicts preterm births 2 months in advance
Mirvie is aiming to open a diagnostic window in the second trimester, expanding treatment options for patients predicted to experience preterm birth.
Andrea Park
Apr 13, 2022 11:57am
Takeda shunts jewel of Shire takeover to new spinoff Oak Hill
Feb 1, 2022 8:30am
Sera raises $36M to market its premature birth-risk blood test
Nov 14, 2019 11:52am
New discoveries in preterm birth and heart disease—News of Note
Jun 11, 2018 1:31pm
Protecting preemies with spider silk
May 25, 2017 4:16pm
